MedPath

Comparison of the efficacy and side effects of desloratadine with fexofenadine on allergic rhinitis in patients referred to Masih Daneshvari Hospital

Phase 2
Recruiting
Conditions
Allergic rhinitis.
Allergic rhinitis due to pollen
J30.1
Registration Number
IRCT20160516027929N11
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
65
Inclusion Criteria

Age over 12 years
History of allergic rhinitis or diagnosis at first visit
Written consent to participate in the study

Exclusion Criteria

Sensitivity, allergy or adverse reaction to desloratadine and fexofenadine
Patients who have previously been treated with two or more drugs
pregnancy and breastfeeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
General clinical symptoms. Timepoint: Before starting treatment and 10 weeks after starting treatment. Method of measurement: Rhinitis Quality of Life Questionnaire.;The severity of eye symptoms. Timepoint: Rhinitis Quality of Life Questionnaire. Method of measurement: Rhinitis Quality of Life Questionnaire.;Severe itching in the nose. Timepoint: Rhinitis Quality of Life Questionnaire. Method of measurement: Rhinitis Quality of Life Questionnaire.;Sleep disorders. Timepoint: Rhinitis Quality of Life Questionnaire. Method of measurement: Rhinitis Quality of Life Questionnaire.
Secondary Outcome Measures
NameTimeMethod
Evaluation of the clinical symptoms of allergic rhinitis. Timepoint: Before starting treatment and 10 weeks after starting treatment. Method of measurement: Physical examination.
© Copyright 2025. All Rights Reserved by MedPath